DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will release its financial results for Q2 2022, the period ended June 30, 2022, next week. The report will be issued on Monday, Aug. 15, 2022. In addition, the company has scheduled a conference call and webcast to discuss the report. That call will be on the same day — Aug. 15, 2022 — and will begin at 8:30 a.m. ET. Company management, including CEO Erez Raphael, CFO Zvi Ben-David, and North America president and GM Rick Anderson, will host the call. To participate in the call, individuals can dial 877-451-6152 and use conference ID 13732068; international callers should dial 201-389-0879 and use the same conference ID. Callers are encouraged to dial in at least 10 minutes before the event is scheduled to begin. A reply of the call will also be available through Sept. 15, 2022; that archived event can be accessed by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and using the passcode 13732068.
To view the full event, visit https://ibn.fm/DkIJI
To view the full press release, visit https://ibn.fm/pPllS
About DarioHealth Corp.
DarioHealth Corp. is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
